Overview
SIGA Q2 product revenues rise to $79 mln, driven by TPOXX sales
Company awarded $27 mln in BARDA 19C contract funding for development
Net income for Q2 jumps to $35.5 mln, reflecting strong performance
Result Drivers
TPOXX SALES - $53 mln from oral TPOXX and $26 mln from IV TPOXX sales to Strategic National Stockpile
BARDA FUNDING - $27 mln awarded for TPOXX pediatric program and manufacturing support under BARDA 19C contract
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 EPS |
| $0.49 |
|
Q2 Net Income |
| $35.50 mln |
|
Analyst Coverage
The stock recently traded at 6 times the next 12-month earnings vs. a P/E of 5 three months ago
Press Release: ID:nGNX7jGW8k